PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 176 filers reported holding PRECIGEN INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,140 | +23.5% | 17,000 | 0.0% | 0.01% | +20.0% |
| Q2 2023 | $19,550 | +8.5% | 17,000 | 0.0% | 0.01% | +25.0% |
| Q1 2023 | $18,020 | -30.3% | 17,000 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $25,840 | -28.2% | 17,000 | 0.0% | 0.01% | -62.5% |
| Q3 2022 | $36,000 | +56.5% | 17,000 | 0.0% | 0.02% | +166.7% |
| Q2 2022 | $23,000 | -36.1% | 17,000 | 0.0% | 0.01% | -50.0% |
| Q1 2022 | $36,000 | -42.9% | 17,000 | 0.0% | 0.01% | -7.7% |
| Q4 2021 | $63,000 | -25.9% | 17,000 | 0.0% | 0.01% | -56.7% |
| Q3 2021 | $85,000 | -23.4% | 17,000 | 0.0% | 0.03% | -18.9% |
| Q2 2021 | $111,000 | -5.1% | 17,000 | 0.0% | 0.04% | -11.9% |
| Q1 2021 | $117,000 | -55.2% | 17,000 | -33.6% | 0.04% | -54.8% |
| Q4 2020 | $261,000 | +190.0% | 25,600 | 0.0% | 0.09% | +144.7% |
| Q3 2020 | $90,000 | -29.7% | 25,600 | 0.0% | 0.04% | -32.1% |
| Q2 2020 | $128,000 | +47.1% | 25,600 | 0.0% | 0.06% | +16.7% |
| Q1 2020 | $87,000 | – | 25,600 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |